A new drug quashes all coronavirus variants. But regulatory hurdles and a lack of funding make it unlikely to reach the U.S. market anytime soon. By Benjamin Mueller Over the past year, America’s ...
A single injection of an experimental biologic drug may cut in half your risk of hospitalization from COVID-19 infection, new clinical trial results show. Pegylated lambda interferon (PEG-lambda) ...
Despite potential benefits, the therapy remains in limited use for myeloproliferative neoplasms (MPNs). Pegylated interferons are a meaningful therapeutic option for the treatment of ...
Interferons are a category of organically rising enzymes that are created by nucleus less cells and mainly exhibit activities alongside viral inflammations and other organic inducers. The three main ...
Interferon therapies are well established as treatment options for some types of cancer, but they have not been used to treat cancers characterized by the overproduction of blood cells. The FDA has ...
GLASGOW, Scotland--(BUSINESS WIRE)--ILC Therapeutics, a UK-based biotechnology company and pioneer in the discovery and development of a new class of interferon drugs, announces the strengthening of ...
GLASGOW, Scotland--(BUSINESS WIRE)--ILC Therapeutics, a UK-based biotechnology company and pioneer in the discovery and development of a ground-breaking new class of interferon drugs, announces the ...
After Cherie Binns had breakthrough multiple sclerosis symptoms while being treated with an interferon drug, she weighed her options carefully. In the end, her neurologist prescribed rituximab. It's a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results